{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Prostate : Questions médicales les plus fréquentes",
"headline": "Prostate : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Prostate : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-24",
"dateModified": "2025-02-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Prostate"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Glandes exocrines",
"url": "https://questionsmedicales.fr/mesh/D005088",
"about": {
"@type": "MedicalCondition",
"name": "Glandes exocrines",
"code": {
"@type": "MedicalCode",
"code": "D005088",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A10.336"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Prostate",
"alternateName": "Prostate",
"code": {
"@type": "MedicalCode",
"code": "D011467",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "A A Kamalov",
"url": "https://questionsmedicales.fr/author/A%20A%20Kamalov",
"affiliation": {
"@type": "Organization",
"name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "L M Samokhodskaya",
"url": "https://questionsmedicales.fr/author/L%20M%20Samokhodskaya",
"affiliation": {
"@type": "Organization",
"name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "V K Karpov",
"url": "https://questionsmedicales.fr/author/V%20K%20Karpov",
"affiliation": {
"@type": "Organization",
"name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "D A Okhobotov",
"url": "https://questionsmedicales.fr/author/D%20A%20Okhobotov",
"affiliation": {
"@type": "Organization",
"name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "V N Mamedov",
"url": "https://questionsmedicales.fr/author/V%20N%20Mamedov",
"affiliation": {
"@type": "Organization",
"name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention.",
"datePublished": "2023-01-04",
"url": "https://questionsmedicales.fr/article/36609003",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.eururo.2022.12.021"
}
},
{
"@type": "ScholarlyArticle",
"name": "Photoelectrochemical immunosensor for carcinoembryonic antigen detection-an attempt for early cancer screening.",
"datePublished": "2022-11-17",
"url": "https://questionsmedicales.fr/article/36413913",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bios.2022.114918"
}
},
{
"@type": "ScholarlyArticle",
"name": "Methylation biomarkers for early cancer detection and diagnosis: Current and future perspectives.",
"datePublished": "2022-10-27",
"url": "https://questionsmedicales.fr/article/36427394",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejca.2022.10.015"
}
},
{
"@type": "ScholarlyArticle",
"name": "Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests.",
"datePublished": "2022-07-18",
"url": "https://questionsmedicales.fr/article/35844011",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40271-022-00589-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection.",
"datePublished": "2023-10-01",
"url": "https://questionsmedicales.fr/article/37352522",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/JS9.0000000000000558"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tissus",
"item": "https://questionsmedicales.fr/mesh/D014024"
},
{
"@type": "ListItem",
"position": 3,
"name": "Glandes exocrines",
"item": "https://questionsmedicales.fr/mesh/D005088"
},
{
"@type": "ListItem",
"position": 4,
"name": "Prostate",
"item": "https://questionsmedicales.fr/mesh/D011467"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Prostate - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Prostate",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Prostate",
"description": "Comment diagnostiquer un cancer de la prostate ?\nQuels tests sont utilisés pour évaluer la prostate ?\nQuand faut-il faire un dépistage de la prostate ?\nQuels symptômes indiquent un problème de prostate ?\nQuel rôle joue l'examen rectal ?",
"url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Early+Detection+of+Cancer&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Prostate",
"description": "Quels sont les symptômes d'une hypertrophie bénigne de la prostate ?\nLa douleur pelvienne est-elle un symptôme courant ?\nComment reconnaître une infection de la prostate ?\nLes problèmes d'érection sont-ils liés à la prostate ?\nLe sang dans les urines est-il alarmant ?",
"url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Early+Detection+of+Cancer&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Prostate",
"description": "Peut-on prévenir le cancer de la prostate ?\nQuel rôle joue l'alimentation dans la prévention ?\nL'exercice physique aide-t-il à prévenir les problèmes de prostate ?\nLe tabagisme influence-t-il le risque de cancer de la prostate ?\nLes examens réguliers sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Early+Detection+of+Cancer&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Prostate",
"description": "Quels traitements existent pour le cancer de la prostate ?\nComment traiter l'hypertrophie bénigne de la prostate ?\nQu'est-ce que l'hormonothérapie ?\nLa radiothérapie est-elle efficace ?\nQuels sont les effets secondaires des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Early+Detection+of+Cancer&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Prostate",
"description": "Quelles sont les complications du cancer de la prostate ?\nLes traitements peuvent-ils causer des complications ?\nQuelles sont les conséquences d'une prostatite non traitée ?\nLe cancer de la prostate peut-il affecter d'autres organes ?\nComment gérer les complications après traitement ?",
"url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Early+Detection+of+Cancer&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Prostate",
"description": "Quels sont les principaux facteurs de risque du cancer de la prostate ?\nL'alimentation influence-t-elle le risque de cancer de la prostate ?\nLe surpoids est-il un facteur de risque ?\nLe niveau d'activité physique joue-t-il un rôle ?\nLes antécédents familiaux augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Early+Detection+of+Cancer&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un cancer de la prostate ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par un examen rectal, un dosage du PSA et une biopsie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la prostate ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'échographie, l'IRM et le dosage du PSA."
}
},
{
"@type": "Question",
"name": "Quand faut-il faire un dépistage de la prostate ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage est recommandé à partir de 50 ans, ou 45 ans pour les personnes à risque."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème de prostate ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des difficultés à uriner, des douleurs pelviennes ou du sang dans les urines peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'examen rectal ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'examen rectal permet de détecter des anomalies de la prostate, comme des nodules."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une hypertrophie bénigne de la prostate ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des mictions fréquentes, un jet urinaire faible et des urgences."
}
},
{
"@type": "Question",
"name": "La douleur pelvienne est-elle un symptôme courant ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur pelvienne peut être un symptôme de prostatite ou de cancer."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une infection de la prostate ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections se manifestent par des douleurs, des mictions douloureuses et de la fièvre."
}
},
{
"@type": "Question",
"name": "Les problèmes d'érection sont-ils liés à la prostate ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles érectiles peuvent être liés à des problèmes de prostate ou à des traitements."
}
},
{
"@type": "Question",
"name": "Le sang dans les urines est-il alarmant ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la présence de sang dans les urines nécessite une évaluation médicale immédiate."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le cancer de la prostate ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode garantie, mais un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'alimentation dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en fruits, légumes et oméga-3 peut aider à réduire le risque."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à prévenir les problèmes de prostate ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut contribuer à maintenir une prostate en bonne santé."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque de cancer de la prostate ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru de développer un cancer de la prostate."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter précocement des problèmes de prostate."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour le cancer de la prostate ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la radiothérapie et l'hormonothérapie."
}
},
{
"@type": "Question",
"name": "Comment traiter l'hypertrophie bénigne de la prostate ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements comprennent des médicaments, des thérapies minimales invasives et la chirurgie."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'hormonothérapie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hormonothérapie vise à réduire les niveaux d'hormones qui stimulent la croissance du cancer."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie est un traitement efficace pour le cancer localisé de la prostate."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des troubles urinaires, des dysfonctionnements érectiles et de la fatigue."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du cancer de la prostate ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure la propagation du cancer, des douleurs chroniques et des problèmes urinaires."
}
},
{
"@type": "Question",
"name": "Les traitements peuvent-ils causer des complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent entraîner des effets secondaires comme des troubles urinaires et érectiles."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une prostatite non traitée ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une prostatite non traitée peut entraîner des infections récurrentes et des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Le cancer de la prostate peut-il affecter d'autres organes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le cancer peut se propager aux os, aux ganglions lymphatiques et à d'autres organes."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications après traitement ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications peut inclure des médicaments, des thérapies physiques et un suivi médical."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du cancer de la prostate ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, les antécédents familiaux et l'origine ethnique."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque de cancer de la prostate ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses animales peut augmenter le risque de cancer."
}
},
{
"@type": "Question",
"name": "Le surpoids est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le surpoids et l'obésité sont associés à un risque accru de cancer de la prostate."
}
},
{
"@type": "Question",
"name": "Le niveau d'activité physique joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut augmenter le risque de développer un cancer de la prostate."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir un parent proche atteint de cancer de la prostate augmente le risque personnel."
}
}
]
}
]
}
Prostate cancer (PCa) is a leading cause of death and partially heritable. Genetic risk prediction might be useful for strategies to reduce PCa mortality through early detection and prevention....
To review evidence for genetic risk prediction for PCa....
A collaborative literature review was conducted using PubMed and Google Scholar. Search terms included genetic, risk, prediction, and "prostate cancer". Articles addressing screening, early detection,...
Rare pathogenic mutations (RPMs), especially in DNA damage repair genes, increase PCa risk. RPMs in BRCA2 are most clearly deleterious, conferring 2-8.6 times higher risk of PCa and a higher risk of a...
Genetic risk assessment is becoming more common; implementation studies are needed to understand the implications and to avoid exacerbating healthcare disparities. Men with a high genetic risk of PCa ...
Prostate cancer risk is inherited through rare mutations and through the combination of hundreds of common genetic markers. Some men with a high genetic risk (especially BRCA2 mutations) likely benefi...
A photoelectrochemical (PEC) immunosensor based on MIL-101(Cr) and CdTe-QDs composites (M&C) was successfully synthesized to assay the carcinoembryonic antigen (CEA) in human serum and urine samples. ...
The increase in recent scientific studies on cancer biomarkers has brought great new insights into the field. Moreover, novel technological breakthroughs such as long read sequencing and microarrays h...
Emerging blood-based multi-cancer early detection (MCED) tests can detect a variety of cancer types across stages with a range of sensitivity, specificity, and ability to predict the origin of the can...
To quantify preferences for MCED tests among US adults aged 50-80 years using a discrete choice experiment (DCE)....
To quantify preferences for attributes of blood-based MCED tests, an online DCE was conducted with five attributes (true positives, false negatives, false positives, likelihood of the cancer type unkn...
Participants (N = 1700) were 54% female, mean age 63.3 years. Latent class modeling identified three classes with distinct preferences for MCED tests. The rank order of attribute importance based on r...
While there is significant heterogeneity in cancer screening preferences, the majority of participants preferred MCED screening and the accuracy of these tests is important. While the majority of part...
Poor prognosis of pancreatic ductal adenocarcinoma (PDAC) is mainly due to the lack of effective early-stage detection strategies. Even though the link between inflammation and PDAC has been demonstra...
Plasma samples from 24 PDAC subjects and 22 non-oncological patients have been collected and let to interact with graphene oxide nanosheets.Biomolecular corona formed around graphene oxide nanosheets ...
MagLev profiles resulted significantly different between non-oncological patients and PDAC and allowed to identify a MagLev fingerprint for PDAC. Four inflammatory markers were significantly higher in...
The multiplexed approach discriminated PDAC patients from healthy volunteers in up to 95% of cases. If further confirmed in larger-cohort studies, this approach may be used for PDAC detection....
Despite universal endoscopic screening, early detection of gastric cancer is challenging, led researchers to seek for a novel approach in detecting. Raman spectroscopy measurements as a fingerprint of...
This study evaluated a different form of autoantibody, which is on small extracellular vesicles (sEVs), as a biomarker for early detection of lung cancer. The sEVs were isolated from plasma by ultrace...
Cancer patients benefit from early tumor detection since treatment outcomes are more favorable for less advanced cancers. Platelets are involved in cancer progression and are considered a promising bi...
The lack of early detection in breast cancer management has been identified as the primary factor contributing to the high mortality rate. The introduction of BPJS Kesehatan, Indonesia's national heal...
The study was conducted in 2017 in Yogyakarta, Indonesia. Subjects were recruited using a purposive sampling technique with maximum variation. The sample comprised breast cancer patients, health care ...
This study identified several issues that hinder the timely detection of breast cancer. The lack of both screening and diagnostic procedures emerged as a prominent obstacle in breast cancer management...
This study revealed multiple factors contributing to the delay in breast cancer detection in Indonesia, leading to suboptimal management of the disease. It is crucial for the government to prioritize ...
Esophageal cancer (EC) is a significant global health problem, with an estimated 7th highest incidence and 6th highest mortality rate. Timely diagnosis and treatment are critical for improving patient...
We conducted a comprehensive systematic search of five databases (PubMed, Scopus, Web of Science, Wiley, and IEEE) using search terms such as "ML", "Deep Learning (DL (", "Neural Networks (NN)", "Esop...
The results of this review highlight the potential of ML-based methods in the early detection of EC. The average accuracy of the reviewed methods in the analysis of endoscopic and computed tomography ...
Our findings suggest that ML methods may improve accuracy in the early detection of EC, potentially supporting radiologists, endoscopists, and pathologists in diagnosis and treatment planning. However...